HemoShear Therapeutics, Inc. has announced that the first two patients have been dosed in Phase 2 clinical trial of HST5040.
Rivanna’s international sales of the Accuro device generated 73% of their Quarter 2 revenue, indicating the success of their expanding global distribution footprint.
Six Charlottesville area biotech companies receive Commonwealth Commercialization Fund grants from the state
Charlottesville based companies Advaray, AgroSpheres, Bonumose, Cerillo, Contraline, and Icarus Medical are among those awarded in inaugural round of Commonwealth Commercialization Fund awards.
The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and clinical research organization.
A Charlottesville-based pharmaceutical company that recently began clinical trials of its Alzheimer’s treatment hit the stock market Thursday with an initial public offering it hopes will raise about $160 million.
Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia
Rivanna®, developers of world-first imaging-based medical solutions, today announced the results of a recent randomized controlled trial.
Springbok Analytics is pleased to announce its newest partnership with Proactive Sports Performance, the California based off-season home to some of the world’s most elite athletes.
Sanford Health vascular surgeon Patrick Kelly, M.D., has invented a unique device to transform treatment of blood clots in the lungs that kill as many as 100,000 Americans each year.
Ireland’s Kerry Group has added to its stable of probiotics with a deal announced today with VA-based biotech firm BIO-CAT Microbials, LLC.